News

Skin cancer is the most common cancer in the United States, with an estimated 1 in 5 Americans developing skin cancer in their lifetime. This summer season, Megan McNally, MD, a fellowship-trained surgical oncologist with Saint Luke's Cancer Institute, joined KCTV to share helpful insights on skin safety.

After seeking a second opinion at Saint Luke's, Mark Levin now walks tall—and pain free—knowing the right medical team, and a little faith, can work wonders.

BBC News talked to Dr. Mikhail Kosiborod about new findings on the cardiovascular effects of semaglutide.

A new subanalysis presented by Dr. Mikhail Kosiborod shows benefits of semaglutide in patients with atrial fibrillation.

When John Murray was losing function in his hands and arms, it became difficult to play his music. He turned to the team at Saint Luke's Marion Bloch Neuroscience Institute to fix the issue threatening his independent lifestyle.